Therapeutic perspectives of p-coumaric acid: Anti-necrotic, anti-cholestatic and anti-amoebic activities
World Academy of Sciences Journal, ISSN: 2632-2919, Vol: 3, Issue: 5
2021
- 26Citations
- 48Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Review Description
Phenolic acids are phytochemical compounds derived from plant biomass materials, that have notable health benefits with high therapeutic potential in several diseases. p-coumaric acid (p-CA) is a phenolic acid that displays various biological activities, such as antioxidant, anti-inflammatory, analgesic and anti-antimicrobial properties. However, the ability of p-CA to prevent hepatic necrosis and cholestasis induced by various harmful agents has not yet been explored to date, at least to the best of our knowledge, and there is no evidence that p-CA exerts an anti-parasitic effect. Therefore, the present study employed male Wistar rats, and the study was divided into two experimental in vivo parts. A liver necrosis model was established using carbon tetrachloride (CCl4) for 24 h, and a cholestasis model induced by common bile duct ligation (BDL) for 48 h was also established. On the other hand, the Entamoeba histolytica HM1:IMSS strain was used as in vitro model employing Trypan blue cell viability assay. The results revealed that p-CA treatment significantly reduced the levels of the necrosis biomarker, alanine aminotransferase, and completely prevented the increase in the levels of the cholestasis markers, alkaline phosphatase and γ-glutamyl transpeptidase in rats intoxicated with CCl4 a s well a s i n those subjected to BDL. Macroscopic observations and the hematoxylin and eosin staining results were consistent with the biochemical determinations, providing evidence of the hepatoprotective effects of p-CA. Moreover, 500 μM p-CA inhibited the growth of Entamoeba histolytica, 26.5% at 12 h and 41.5% at 24 h compared with the controls. Thus, to the best of our knowledge, these findings provide the first evidence that p-CA prevents liver damage induced by CCl4 or BDL (necrosis and cholestasis) and exhibits amoebostatic activity against Entamoeba histolytica.
Bibliographic Details
Spandidos Publications
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know